A Kodak moment for the books: the former film giant flipped to pharma in a move aimed to rejuvenate the company after nearly two decades of hardship. Several reports state that Kodak branched out to offset the large-scale loss of its film business – punctuated by a bankruptcy in 2012 after the concept of the digital camera that it invented rendered many of its product offerings obsolete.
Initial talks of Kodak’s new active pharmaceutical ingredients (APIs) division, branded “Kodak Pharmaceuticals,” began as early as a few months ago according to Kodak CEO Jim Continenza. He says the move shouldn’t be all that surprising.
Read More
